SIGN UP
LOG IN
A
ANVS
Annovis Bio Inc
1.57
-0.07-4.27%After Hours: 1.600 +0.030 +1.90%19:06 04/25 EDT
OPEN/PREV CLOSE1.630/1.640
TODAY RANGE1.490-1.640
VOL269.28K
MARKET CAP30.59M
52 WEEK RANGE1.110-20.00
AVG VOL (3M)490.67K
% TURNOVER1.38%
TURNOVER--
P/E (TTM)-0.7778
% RANGE9.15%
EPS(TTM)-2.0185
P/E(FORWARD)-0.7530
P/B2.385
BVPS0.6582
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP26.17M
SHARES OUTSTANDING19.49M
NEXT EARNINGS05/08-05/12
FREE FLOAT16.67M
LOT SIZE1
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·1d ago
Biotech Alert: Searches spiking for these stocks today
Benzinga·4d ago
12 Health Care Stocks Moving In Monday's Intraday Session
Dow Jones·03/27 21:33
*Annovis Bio: By Mutual Agreement, William Fricker Will No Longer Be Interim CFO
TipRanks·03/27 20:56
Annovis Bio receives noncompliance notification from NYSE
TipRanks·03/27 20:55
Annovis Bio Faces NYSE Non-Compliance Notice
Seeking Alpha·03/27 20:45
Annovis Bio receives NYSE notice over non-compliance with listing rules
Seeking Alpha·03/21 21:17
Annovis Bio GAAP EPS of -$0.43 misses by $0.13
TipRanks·03/21 21:10
Annovis Bio reports Q4 EPS (43c) vs. ($2.24) last year
Dow Jones·03/21 21:06
*Annovis Bio Sees Funding Sufficient Into 4Q >ANVS
Dow Jones·03/21 21:05
Press Release: Annovis Provides Corporate Updates -2-
Dow Jones·03/21 21:05
*Annovis Bio 4Q Loss/Shr 43c >ANVS
Dow Jones·02/10 12:17
Annovis Bio Cut to Hold From Buy by D. Boral Capital
TipRanks·02/10 12:11
Annovis Bio downgraded to Hold from Buy at D. Boral Capital
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.